New Age Alpha Advisors, LLC Tg Therapeutics, Inc. Transaction History
New Age Alpha Advisors, LLC
- $2.39 Trillion
- Q3 2025
A detailed history of New Age Alpha Advisors, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 7,021 shares of TGTX stock, worth $217,651. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,021
Previous 7,221
2.77%
Holding current value
$217,651
Previous $260 Million
2.4%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding TGTX
# of Institutions
397Shares Held
92.7MCall Options Held
1.77MPut Options Held
1.9M-
Vanguard Group Inc Valley Forge, PA15.5MShares$481 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$353 Million0.0% of portfolio
-
State Street Corp Boston, MA8.1MShares$251 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY4.64MShares$144 Million0.13% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.84MShares$119 Million8.45% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.5B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...